7Baggers

Alexander & Baldwin Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 016.7333.4650.1966.9183.64100.37117.1Milllion

Alexander & Baldwin Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2012-12-31 
                                                 
  assets                                               
  real estate investments1,496,272,000 1,499,444,000 1,498,744,000 1,488,179,000 1,469,972,000 1,474,805,000 1,483,000,000 1,502,600,000 1,505,400,000 1,500,500,000 1,507,600,000 1,519,100,000 1,519,200,000 1,523,200,000 1,533,100,000 1,626,800,000 1,638,800,000 1,652,900,000 1,667,000,000 1,670,700,000 1,678,600,000 1,690,300,000 1,700,100,000 1,715,000,000 1,728,700,000 1,567,500,000                      
  real estate property1,682,017,000 1,676,343,000 1,670,879,000 1,644,293,000 1,610,927,000 1,612,280,000 1,609,000,000 1,619,900,000 1,614,300,000 1,600,700,000 1,598,900,000 1,598,300,000 1,589,000,000 1,590,900,000 1,588,200,000 1,569,300,000 1,564,600,000 1,557,200,000 1,549,700,000 1,544,100,000 1,541,400,000 1,537,700,000 1,540,200,000 1,531,400,000 1,501,900,000 1,342,100,000                      
  accumulated depreciation-271,006,000 -263,283,000 -255,641,000 -249,281,000 -241,888,000 -234,564,000 -227,300,000 -223,000,000 -216,500,000 -209,300,000 -202,300,000 -197,600,000 -190,600,000 -187,800,000 -180,500,000 -174,400,000 -167,800,000 -161,000,000 -154,400,000 -148,000,000 -141,400,000 -133,900,000 -127,500,000 -124,300,000 -118,300,000 -112,400,000                      
  real estate developments41,506,000 41,466,000 46,423,000 54,696,000 60,856,000 55,531,000 58,100,000 60,000,000 60,000,000 59,900,000 59,900,000 64,800,000 64,600,000 61,900,000 65,000,000 68,900,000 68,800,000 73,600,000 75,700,000 77,300,000 77,900,000 81,900,000 79,100,000 93,800,000 125,200,000 136,300,000 124,100,000 141,900,000 139,600,000 142,000,000 151,000,000 151,700,000 184,500,000 184,000,000 179,500,000 192,600,000 188,500,000 184,900,000 183,500,000 181,200,000 179,500,000 199,100,000 224,000,000 254,400,000 252,700,000 248,200,000 144,000,000 
  investments in sales-type leases, net of allowances (credit losses) of 18 as of june 30, 20259,421,000                                               
  investments in real estate joint ventures and partnerships5,907,000 5,907,000 5,907,000 5,907,000 6,765,000 6,828,000 6,900,000 7,400,000 7,400,000 7,400,000 7,500,000 8,200,000 8,800,000 8,800,000 8,800,000 109,100,000 116,800,000 124,000,000 134,100,000 132,400,000 132,800,000 133,400,000 133,400,000 135,400,000 137,600,000 140,500,000                      
  real estate intangible assets28,427,000 29,795,000 31,176,000 32,564,000 33,312,000 34,730,000 36,300,000 38,300,000 40,200,000 41,800,000 43,600,000 45,400,000 47,400,000 49,400,000 51,600,000 53,900,000 56,400,000 59,100,000 61,900,000 64,900,000 67,900,000 71,200,000 74,900,000 78,700,000 82,300,000 61,000,000                      
  cash and cash equivalents8,579,000 16,855,000 33,436,000 17,919,000 29,523,000 15,683,000 13,500,000 11,800,000 8,200,000 10,700,000 33,300,000 7,300,000 33,200,000 33,700,000 70,000,000 26,500,000 19,900,000 32,000,000 57,200,000 117,100,000 96,200,000 131,600,000 15,200,000 7,200,000 5,500,000 3,000,000 11,400,000 7,500,000 9,500,000 26,500,000 68,900,000 13,300,000 11,000,000 15,300,000 2,200,000 5,800,000 6,400,000 3,500,000 1,300,000 4,100,000 2,300,000 3,400,000 2,800,000 9,200,000 6,200,000 5,500,000 1,100,000 
  restricted cash1,518,000 697,000 236,000 236,000 236,000 236,000 200,000 200,000 200,000 1,000,000 1,000,000 200,000 200,000 1,000,000 1,000,000 200,000 200,000 200,000 200,000 200,000 200,000 6,100,000 200,000 200,000 200,000 187,900,000 223,500,000 200,000 200,000 17,100,000 34,300,000                 
  accounts receivable4,097,000 4,942,000 3,697,000 3,501,000 4,580,000 3,715,000 4,500,000 3,600,000 5,200,000 4,200,000 6,100,000            43,400,000    49,600,000 60,300,000 54,700,000 37,500,000 34,100,000 34,200,000 39,700,000 30,000,000              
  goodwill8,729,000 8,729,000 8,729,000 8,729,000 8,729,000 8,729,000 8,700,000 8,700,000 8,700,000 8,700,000 8,700,000 8,700,000 8,700,000 8,700,000 8,700,000 10,500,000 10,500,000 10,500,000 10,500,000 10,500,000 10,500,000 15,400,000 15,400,000 15,400,000 65,100,000 65,100,000 65,100,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,300,000 102,900,000 100,000,000 100,000,000  
  other receivables, net of allowances (credit losses) of 2,208 and 2,393 as of june 30, 2025 and december 31, 2024, respectively8,725,000                                               
  prepaid expenses and other assets114,453,000 106,762,000 108,894,000 104,795,000 101,204,000 103,711,000 97,000,000 102,600,000 91,200,000 92,600,000 89,000,000 133,900,000 121,600,000 108,100,000 102,600,000 105,400,000 90,500,000 95,100,000 95,600,000    97,100,000 109,400,000 102,600,000 115,100,000 15,900,000 41,300,000 38,400,000 14,700,000 11,400,000 39,400,000 34,400,000 15,900,000 19,600,000 12,600,000 9,100,000 14,700,000 14,900,000 11,400,000 15,400,000 20,800,000 15,600,000 18,600,000 15,200,000 18,300,000 11,300,000 
  total assets1,642,373,000 1,648,614,000 1,670,432,000 1,650,002,000 1,641,909,000 1,636,290,000 1,646,200,000 1,785,900,000 1,784,900,000 1,756,100,000 1,787,300,000 1,847,900,000 1,854,100,000 1,854,600,000 1,879,800,000 1,963,500,000 1,956,000,000 1,991,900,000 2,036,000,000 2,114,900,000 2,106,200,000 2,174,600,000 2,084,300,000 2,121,700,000 2,184,500,000 2,249,600,000 2,225,200,000 2,276,200,000 2,272,200,000 2,310,700,000 2,231,200,000 2,208,300,000 2,177,000,000 2,160,600,000 2,156,300,000 2,224,200,000 2,239,200,000 2,319,000,000 2,243,500,000 2,245,500,000 2,269,600,000 2,288,200,000 2,329,900,000 2,295,200,000 2,283,700,000 2,295,500,000 1,437,300,000 
  liabilities and equity                                               
  liabilities:                                               
  notes payable and other debt450,297,000 452,843,000 474,837,000 472,179,000 469,804,000 457,574,000 464,000,000 507,600,000 506,900,000 479,200,000 472,200,000 469,700,000 475,900,000 522,200,000 532,700,000 627,700,000 597,800,000 654,600,000 687,100,000 763,600,000 768,600,000 819,600,000 704,600,000 732,400,000 727,700,000 775,000,000                      
  accounts payable6,600,000 4,490,000 4,529,000 4,910,000 5,241,000 4,350,000 5,800,000 6,100,000 5,200,000 4,900,000 4,500,000 18,500,000 14,800,000 13,200,000 9,900,000 11,400,000 12,400,000 13,200,000 9,800,000 10,400,000 12,400,000 12,300,000 17,800,000 15,000,000 19,300,000 26,700,000 34,200,000 33,700,000 40,100,000 32,600,000 43,300,000 36,000,000 32,200,000 31,600,000 35,200,000 30,100,000 27,300,000 28,800,000 35,500,000 30,100,000 35,600,000 32,400,000 37,600,000 37,100,000 32,200,000 31,800,000 26,200,000 
  accrued post-retirement benefits7,482,000 7,535,000 7,582,000 8,173,000 8,216,000 8,275,000                                          
  refund liability45,300,000                                               
  deferred revenue10,245,000 75,085,000 72,462,000 72,499,000 71,243,000 72,460,000 70,400,000 71,900,000 71,800,000 71,900,000 68,800,000 71,300,000 68,700,000 70,000,000 68,500,000 69,800,000 70,700,000 68,700,000 66,900,000 68,000,000 66,800,000 67,400,000 67,600,000 68,400,000 65,900,000 65,400,000 63,100,000   3,000,000 900,000 2,700,000 100,000 1,900,000 17,600,000   1,900,000 100,000 1,800,000 2,500,000 1,700,000 16,500,000 1,700,000 100,000 13,300,000  
  accrued and other liabilities109,417,000 103,518,000 107,479,000 94,059,000 85,833,000 87,305,000 91,800,000 78,400,000 80,300,000 81,700,000 102,100,000 105,900,000 103,300,000 96,400,000 119,500,000 99,600,000 109,100,000 95,700,000 116,500,000 102,200,000 93,400,000 102,900,000 95,500,000 107,700,000 97,200,000 92,300,000 41,500,000 46,300,000 43,000,000 21,900,000 27,500,000 28,600,000 29,100,000 26,500,000 31,700,000 36,200,000 33,300,000 33,400,000 41,300,000 33,200,000 32,700,000 28,600,000 35,800,000 33,000,000 30,300,000 26,600,000 22,700,000 
  total liabilities629,341,000 643,471,000 666,889,000 651,820,000 640,337,000 629,964,000 643,200,000 747,400,000 752,000,000 728,500,000 743,600,000 712,600,000 710,400,000 776,800,000 806,300,000 863,400,000 847,100,000 885,600,000 933,400,000 998,300,000 995,400,000 1,057,600,000 949,300,000 985,400,000 984,000,000 1,036,200,000 1,009,000,000 919,600,000 933,800,000 977,500,000 1,572,100,000 974,400,000 948,600,000               
  commitments and contingencies                                               
  equity:                                               
  common stock - no par value; authorized, 225,000,000 shares; outstanding 72,753,270 and 72,633,866 shares at june 30, 2025 and december 31, 2024, respectively1,813,100,000                                               
  accumulated other comprehensive income504,000 2,506,000 6,134,000 -2,059,000 5,208,000 3,979,000 3,200,000 8,600,000 1,500,000 -2,200,000 1,800,000 4,500,000 1,900,000 -72,800,000 -80,700,000 -59,700,000 -56,100,000 -56,000,000 -60,000,000 -53,900,000 -55,100,000 -55,100,000 -48,800,000 -55,000,000 -54,000,000 -52,600,000 -51,900,000 -38,300,000 -39,400,000                   
  distributions in excess of accumulated earnings-800,572,000 -809,189,000 -814,173,000 -810,202,000 -812,907,000 -805,662,000 -809,300,000 -789,600,000 -788,100,000 -785,400,000 -774,500,000 -686,700,000 -677,100,000 -666,400,000 -663,200,000 -656,000,000 -649,200,000 -650,400,000 -649,400,000 -640,400,000 -643,400,000 -638,700,000 -626,200,000 -617,600,000 -554,000,000 -541,300,000  -410,500,000 -426,000,000 -428,400,000                  
  total shareholders' equity1,013,032,000 1,005,143,000 1,003,543,000 998,182,000 1,001,572,000 1,006,326,000                                          
  total liabilities and equity1,642,373,000 1,648,614,000 1,670,432,000 1,650,002,000 1,641,909,000 1,636,290,000 1,646,200,000 1,785,900,000 1,784,900,000 1,756,100,000 1,787,300,000 1,847,900,000 1,854,100,000 1,854,600,000 1,879,800,000 1,963,500,000 1,956,000,000 1,991,900,000 2,036,000,000 2,114,900,000 2,106,200,000 2,174,600,000 2,084,300,000 2,121,700,000 2,184,500,000 2,249,600,000 2,225,200,000 2,276,200,000 2,272,200,000 2,310,700,000 2,231,200,000 2,208,300,000 2,177,000,000 2,160,600,000 2,156,300,000 2,224,200,000 2,239,200,000 2,319,000,000 2,243,500,000 2,245,500,000 2,269,600,000 2,288,200,000 2,329,900,000 2,295,200,000 2,283,700,000 2,295,500,000  
  investments in sales-type leases, net of allowances (credit losses) of 17 as of march 31, 2025 9,216,000                                              
  other receivables, net of allowances (credit losses) of 2,299 and 2,393 as of march 31, 2025 and december 31, 2024, respectively 11,185,000                                              
  common stock - no par value; authorized, 225,000,000 shares; outstanding 72,711,539 and 72,633,866 shares at march 31, 2025 and december 31, 2024, respectively 1,811,826,000                                              
  other receivables, net of allowance (credit losses and doubtful accounts) of 2,393 and 3,545 as of december 31, 2024 and 2023, respectively  16,696,000                                             
  assets held for sale   14,036,000 13,999,000 14,004,000 14,000,000 144,700,000 154,900,000 125,100,000 126,800,000                                     
  common stock - no par value; authorized, 225,000,000 shares; outstanding 72,633,866 and 72,447,510 shares at december 31, 2024 and 2023, respectively  1,811,582,000                                             
  other receivables, net of allowances of 2,264 and 3,545 as of september 30, 2024, and december 31, 2023, respectively   12,607,000                                            
  common stock - no par value; authorized, 225,000,000 shares; outstanding, 72,632,947 and 72,447,510 shares at september 30, 2024, and december 31, 2023, respectively   1,810,443,000                                            
  other receivables, net of allowances of 3,653 and 3,545 as of june 30, 2024, and december 31, 2023, respectively    13,666,000                                           
  common stock - no par value; authorized, 225,000,000 shares; outstanding, 72,621,777 and 72,447,510 shares at june 30, 2024, and december 31, 2023, respectively    1,809,271,000                                           
  other receivables, net of allowances of 3,565 and 3,545 as of march 31, 2024, and december 31, 2023, respectively     15,407,000                                          
  common stock - no par value; authorized, 225,000,000 shares; outstanding, 72,592,147 and 72,447,510 shares at march 31, 2024, and december 31, 2023, respectively     1,808,009,000                                          
  operating lease right-of-use assets      1,700,000 2,200,000 2,600,000 3,000,000 5,400,000 37,000,000 37,400,000 19,300,000 20,100,000 21,200,000 22,100,000 18,200,000 18,600,000 19,500,000 20,000,000 20,900,000 21,800,000 22,700,000 28,500,000 30,000,000                      
  other receivables, net of allowances of 3.5 million and 2.7 million as of december 31, 2023 and 2022, respectively      23,600,000                                         
  operating lease liabilities      1,100,000 2,000,000 2,000,000 2,900,000 4,900,000 36,800,000 36,700,000 18,900,000 19,400,000 21,400,000 21,900,000 18,500,000 18,400,000 19,700,000 19,800,000 21,100,000 21,600,000 23,000,000 28,500,000 30,400,000                      
  accrued pension and post-retirement benefits      10,000,000 10,100,000 10,100,000 10,100,000 10,100,000 10,400,000 11,000,000 56,100,000 56,300,000 33,500,000 35,200,000 34,900,000 34,700,000 26,900,000 26,900,000 26,800,000 26,800,000 31,400,000 30,800,000 30,100,000    20,100,000 19,900,000 16,700,000 63,700,000 64,900,000 64,800,000    59,700,000    54,800,000     
  liabilities associated with assets held for sale      100,000 71,300,000 75,700,000 77,800,000 81,000,000                                     
  redeemable noncontrolling interest       9,700,000 9,200,000 7,600,000 8,000,000 8,100,000 7,700,000 7,400,000 6,900,000 6,800,000 6,700,000 6,500,000 6,500,000 6,400,000 6,200,000 6,200,000 6,300,000 7,900,000 7,900,000 7,900,000 7,900,000 8,000,000 8,000,000 8,000,000 8,000,000 10,800,000 10,800,000 10,800,000 10,800,000 11,600,000 11,600,000 11,600,000 11,600,000 9,800,000        
  common stock - no par value; authorized, 225.0 million shares; outstanding 72.4 million and 72.5 million shares as of december 31, 2023 and 2022, respectively      1,809,100,000                                         
  total a&b shareholders' equity      1,003,000,000 1,028,800,000 1,023,700,000 1,020,000,000 1,035,700,000    1,066,600,000    1,096,100,000 1,110,200,000 1,104,600,000 1,107,800,000 1,125,100,000 1,124,800,000 1,187,900,000 1,200,100,000 1,202,600,000 1,343,300,000 1,325,400,000 1,320,600,000 646,400,000 1,218,900,000 1,213,400,000 1,210,600,000 1,209,300,000 1,211,100,000 1,213,400,000 1,216,300,000 1,223,600,000 1,242,200,000 1,237,200,000 1,227,500,000 1,203,900,000 1,218,700,000 1,208,700,000 1,199,500,000  
  other property       2,200,000 2,200,000 2,300,000 2,500,000 69,600,000 68,500,000 83,800,000 83,500,000 108,100,000 108,400,000 108,700,000 110,800,000 111,200,000 119,800,000 122,400,000 124,400,000 131,400,000 127,300,000 128,900,000                      
  other receivables, net of allowances of 3.7 million and 2.7 million as of september 30, 2023, and december 31, 2022, respectively       7,300,000                                        
  common stock - no par value; authorized, 225.0 million shares; outstanding, 72.5 million and 72.5 million shares at september 30, 2023 and december 31, 2022, respectively       1,809,800,000                                        
  other receivables, net of allowances of 3.6 million and 2.7 million as of june 30, 2023, and december 31, 2022, respectively        6,300,000                                       
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.6 million and 72.5 million shares at june 30, 2023 and december 31, 2022, respectively        1,810,300,000                                       
  other receivables, net of allowances of 3.6 million and 2.7 million as of march 31, 2023, and december 31, 2022, respectively         8,000,000                                      
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.6 million and 72.5 million shares at march 31, 2023 and december 31, 2022, respectively         1,807,600,000                                      
  other receivables, net of allowances of 2.7 million and 2.5 million as of december 31, 2022 and 2021, respectively          6,900,000                                     
  common stock - no par value; authorized, 150.0 million shares; outstanding 72.5 million and 72.5 million shares as of december 31, 2022 and 2021, respectively          1,808,400,000                                     
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 1.1 million and 1.3 million as of september 30, 2022, and december 31, 2021, respectively           35,900,000                                    
  inventories           30,100,000 24,600,000 26,100,000 20,300,000 22,200,000 24,100,000 27,200,000 18,400,000 19,300,000 20,200,000 20,700,000 20,700,000 23,900,000 28,200,000 29,000,000 26,500,000 32,200,000 28,700,000 29,600,000 31,900,000 30,100,000 34,100,000 28,000,000 43,300,000 47,300,000 66,000,000 63,700,000 55,900,000 66,200,000 79,800,000 85,100,000 81,900,000 81,000,000 92,100,000 94,800,000 23,500,000 
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 2.2 million and 2.5 million as of september 30, 2022, and december 31, 2021, respectively           6,100,000                                    
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.5 million and 72.5 million shares at september 30, 2022 and december 31, 2021, respectively           1,809,400,000                                    
  total equity           1,127,200,000 1,136,000,000 1,070,400,000  1,093,300,000 1,102,200,000 1,099,800,000 1,096,100,000 1,110,200,000 1,104,600,000 1,110,800,000 1,128,700,000 1,128,400,000 1,192,600,000 1,205,500,000 1,208,300,000 1,348,600,000 1,330,400,000 1,325,200,000 651,100,000 1,223,100,000 1,217,600,000 1,214,500,000 1,213,200,000 1,214,800,000 1,217,000,000 1,219,900,000 1,227,100,000 1,245,800,000 1,249,000,000 1,239,000,000 1,214,800,000 1,229,600,000 1,219,000,000 1,208,800,000  
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 1.2 million and 1.3 million as of june 30, 2022, and december 31, 2021, respectively            34,900,000                                   
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 2.2 million and 2.5 million as of june 30, 2022, and december 31, 2021, respectively            5,800,000                                   
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.7 million and 72.5 million shares at june 30, 2022 and december 31, 2021, respectively            1,811,200,000                                   
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 1.3 million and 1.3 million as of march 31, 2022, and december 31, 2021, respectively             37,600,000                                  
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 2.5 million and 2.5 million as of march 31, 2022, and december 31, 2021, respectively             13,100,000                                  
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.7 million and 72.5 million shares at march 31, 2022 and december 31, 2021, respectively             1,809,600,000                                  
  accounts receivable and retention, net of allowances (credit losses and doubtful accounts) of 1.3 million and 3.3 million as of december 31, 2021 and 2020, respectively              28,900,000                                 
  other receivables, net of allowances of 2.5 million and 3.9 million as of december 31, 2021 and december 31, 2020, respectively              11,600,000                                 
  common stock - no par value; authorized, 150.0 million shares; outstanding 72.5 million and 72.4 million shares as of december 31, 2021 and 2020, respectively              1,810,500,000                                 
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 1.9 million and 3.3 million as of september 30, 2021 and december 31, 2020, respectively               24,400,000                                
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 3.1 million and 3.9 million as of september 30, 2021 and december 31, 2020, respectively               18,200,000                                
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.5 million and 72.4 million shares at september 30, 2021 and december 31, 2020, respectively               1,809,000,000                                
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 2.3 million and 3.3 million as of june 30, 2021 and december 31, 2020, respectively                24,800,000                               
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 3.5 million and 3.9 million as of june 30, 2021 and december 31, 2020, respectively                16,700,000                               
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.5 million and 72.4 million shares at june 30, 2021 and december 31, 2020, respectively                1,807,500,000                               
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 3.3 million and 3.3 million as of march 31, 2021 and december 31, 2020, respectively                 33,200,000                              
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 3.6 million and 3.9 million as of march 31, 2021 and december 31, 2020, respectively                 13,900,000                              
  common stock - no par value; authorized, 150.0 million shares; outstanding, 72.5 million and 72.4 million shares at march 31, 2021 and december 31, 2020, respectively                 1,806,200,000                              
  accounts receivable and retention, net of allowances (credit losses and doubtful accounts) of 3.3 million and 0.6 million as of december 31, 2020 and 2019, respectively                  43,500,000                             
  other receivables, net of allowances of 3.9 million and 1.6 million as of december 31, 2020 and december 31, 2019, respectively                  14,200,000                             
  common stock - no par value; authorized, 150.0 million shares; outstanding 72.4 million and 72.3 million shares as of december 31, 2020 and 2019, respectively                  1,805,500,000                             
  noncontrolling interest                     3,000,000 3,600,000 3,600,000 4,700,000 5,400,000 5,700,000 5,300,000 5,000,000 4,600,000 4,700,000 4,200,000 4,200,000 3,900,000 3,900,000 3,700,000 3,600,000 3,600,000 3,500,000 3,600,000 11,800,000 11,500,000  10,900,000 10,300,000 9,300,000  
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 4.1 million and 0.6 million as of september 30, 2020 and december 31, 2019, respectively                   52,700,000                            
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 4.5 million and 1.6 million as of september 30, 2020 and december 31, 2019, respectively                   15,800,000                            
  prepaid expenses and other assets, net of allowance for credit losses and allowance for doubtful accounts of 0.1 million and 0 million as of september 30, 2020 and december 31, 2019, respectively                   97,900,000                            
  indemnity holdbacks                   7,500,000 7,500,000 7,500,000 7,500,000 7,500,000 14,600,000 16,300,000                      
  common stock - no par value; authorized, 150 million shares; outstanding, 72.4 million shares at september 30, 2020 and december 31, 2019, respectively                   1,804,500,000                            
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 4.1 million and 0.4 million as of june 30, 2020 and december 31, 2019, respectively                    48,000,000                           
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 4.3 million and 1.6 million as of june 30, 2020 and december 31, 2019, respectively                    14,000,000                           
  prepaid expenses and other assets, net of allowance for credit losses and allowance for doubtful accounts of 0.1 million and 0 million as of june 30, 2020 and december 31, 2019, respectively                    98,700,000                           
  common stock - no par value; authorized, 150 million shares; outstanding, 72.3 million shares at june 30, 2020 and december 31, 2019, respectively                    1,803,100,000                           
  accounts receivable and retention, net of allowance for credit losses and allowance for doubtful accounts of 1.5 million and 0.4 million as of march 31, 2020 and december 31, 2019, respectively                     44,300,000                          
  other receivables, net of allowance for credit losses and allowance for doubtful accounts of 4.6 million and 1.6 million as of march 31, 2020 and december 31, 2019, respectively                     15,000,000                          
  prepaid expenses and other assets, net of allowance for credit losses and allowance for doubtful accounts of 0.1 million and 0 million as of march 31, 2020 and december 31, 2019, respectively                     107,900,000                          
  common stock - no par value; authorized, 150 million shares; outstanding, 72.3 million shares at march 31, 2020 and december 31, 2019, respectively                     1,801,600,000                          
  contracts retention                      8,600,000    11,600,000   12,700,000 13,200,000 12,400,000 12,500,000 12,600,000 13,100,000 12,400,000 12,200,000 12,100,000 11,500,000 10,100,000 9,500,000 9,300,000 9,100,000 9,200,000 9,500,000 8,800,000  
  other receivables                      27,400,000 28,700,000 28,400,000 54,200,000                      
  costs and estimated earnings in excess of billings on uncompleted contracts                      10,000,000    9,200,000 9,600,000 19,900,000 16,200,000 20,200,000 20,700,000 15,500,000 18,500,000 16,400,000 16,600,000 14,000,000 14,300,000 16,300,000 13,900,000 13,400,000 14,100,000 15,900,000 13,500,000 11,800,000 13,100,000  
  billings in excess of costs and estimated earnings on uncompleted contracts                      7,900,000    5,900,000 3,600,000 2,000,000 3,900,000 5,700,000 2,600,000 3,100,000 2,700,000 3,500,000 2,700,000 3,200,000 2,600,000 2,600,000 1,900,000 1,800,000 2,100,000 3,600,000 3,800,000 4,300,000 4,200,000  
  common stock - no par value; authorized, 150 million shares; outstanding, 72.3 million and 72.0 million shares at december 31, 2019 and 2018, respectively                      1,800,100,000                         
  accounts receivable and retention                       67,800,000 70,000,000 68,900,000                      
  common stock - no par value; authorized, 150 million shares; outstanding, 72.3 million and 72.0 million shares at september 30, 2019 and december 31, 2018, respectively                       1,797,400,000                        
  common stock - no par value; authorized, 150 million shares; outstanding, 72.2 million and 72.0 million shares at june 30, 2019 and december 31, 2018, respectively                        1,795,900,000                       
  common stock - no par value; authorized, 150 million shares; outstanding, 72.1 million and 72.0 million shares at march 31, 2019 and december 31, 2018, respectively                         1,794,000,000                      
  current assets:                                               
  real estate development inventory and property held for sale                          31,100,000 23,700,000                    
  income tax receivable                          25,400,000   25,700,000 27,700,000 25,900,000 9,800,000 10,300,000 10,600,000 11,500,000 5,700,000 11,600,000 14,000,000 4,200,000 4,200,000 2,800,000 6,700,000 4,900,000    
  total current assets                          180,700,000 174,600,000 167,100,000 178,500,000 274,800,000 239,800,000 159,000,000 130,600,000 138,300,000 144,600,000 143,200,000 157,900,000 152,500,000 152,900,000 183,300,000 179,200,000 175,900,000 175,000,000 183,800,000 190,100,000 63,400,000 
  investments in affiliates                          171,400,000 379,200,000 388,300,000 397,000,000 401,700,000 402,000,000 398,700,000 395,300,000 390,800,000 430,800,000 432,200,000 422,700,000 416,400,000 413,600,000 409,500,000 403,400,000 418,600,000 348,600,000 342,600,000 344,200,000 319,900,000 
  property – net                          1,322,000,000 1,322,300,000 1,321,000,000 1,317,600,000 1,147,500,000 1,212,400,000 1,235,100,000 1,226,100,000  1,256,100,000 1,275,600,000 1,337,100,000  1,288,900,000 1,286,200,000 1,296,000,000  1,263,600,000 1,266,800,000 1,271,200,000 838,700,000 
  intangible assets – net                          68,400,000 75,900,000 77,800,000 80,500,000 46,900,000 48,700,000 50,300,000 51,900,000              
  deferred income taxes                               202,500,000 182,800,000 182,500,000 182,000,000 184,200,000 183,400,000 197,700,000 202,100,000 5,700,000 8,300,000 8,300,000 8,300,000 9,200,000 7,800,000 7,800,000 7,800,000 
  other assets                          70,000,000 62,200,000 57,500,000 57,100,000 56,200,000 51,400,000 47,100,000 70,400,000 60,000,000 42,000,000 39,300,000 53,700,000 65,000,000 50,100,000 50,000,000 46,500,000 43,500,000 86,400,000 70,300,000 71,100,000 71,300,000 
  current liabilities:                                               
  notes payable and current portion of long-term debt                          39,000,000 37,100,000 35,800,000 42,800,000 46,000,000 41,600,000 44,100,000 48,800,000 42,400,000 82,400,000 88,000,000 91,900,000 90,400,000 47,700,000 48,800,000 71,100,000 74,500,000 46,900,000 46,000,000 51,700,000 15,500,000 
  indemnity holdback related to grace acquisition                          8,800,000   9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 23,500,000 23,500,000 18,800,000  
  accrued dividends                              783,000,000                 
  total current liabilities                          129,400,000 120,700,000 120,900,000 123,300,000 926,800,000 129,600,000 128,200,000 130,900,000 165,100,000 181,500,000 184,000,000 186,200,000 184,700,000 127,100,000 136,200,000 148,500,000 183,000,000 149,300,000 148,000,000 162,500,000 69,600,000 
  long-term liabilities:                                               
  long-term debt                          739,100,000 741,300,000 755,000,000 795,800,000 585,200,000 584,200,000 530,800,000 511,200,000 472,700,000 523,900,000 532,000,000 591,800,000 497,800,000 546,700,000 568,600,000 589,700,000 631,500,000 637,900,000 630,100,000 634,900,000 220,000,000 
  accrued retirement benefits                          28,300,000 23,100,000 23,100,000                   
  other non-current liabilities                          49,100,000 34,500,000 34,800,000 38,300,000 40,200,000 41,400,000 43,100,000 45,800,000 47,700,000 49,600,000 52,500,000 52,300,000 60,500,000 52,000,000 51,200,000 50,500,000 51,800,000 52,800,000 52,800,000 58,800,000 21,500,000 
  total long-term liabilities                          879,600,000 798,900,000 812,900,000 854,200,000 645,300,000 844,800,000 820,400,000 804,400,000 767,200,000 816,300,000 826,600,000 901,300,000 820,100,000 862,800,000 884,400,000 900,700,000 932,100,000 916,300,000 916,700,000 924,200,000 453,300,000 
  common stock - no par value; authorized, 150 million shares; outstanding, 72.0 million and 49.3 million shares at december 31, 2018 and december 31, 2017, respectively                          1,793,400,000                     
  (distribution in excess of accumulated earnings) earnings surplus                          -538,900,000                     
  deferred tax asset                           17,600,000 18,400,000 18,600,000 16,500,000                 
  common stock - no par value; authorized, 150 million shares; outstanding, 72.0 million and 49.3 million shares at september 30, 2018 and december 31, 2017, respectively                           1,792,100,000                    
  real estate held for sale                            15,900,000 15,600,000 67,400,000 63,800,000 2,000,000  1,000,000     700,000 6,600,000  2,500,000   8,900,000 11,500,000 
  common stock                            1,790,800,000 1,789,400,000      1,156,200,000 1,154,800,000 1,153,800,000  1,150,300,000 1,149,200,000 1,147,700,000  1,147,400,000 1,146,000,000 1,144,700,000  
  accrued interest                             5,400,000 6,500,000 3,800,000 5,100,000 3,700,000 6,300,000 3,900,000 5,300,000 3,700,000 5,500,000 3,100,000 5,500,000 3,300,000 5,700,000 3,300,000 5,800,000 3,300,000 5,200,000 
  hc&s cessation-related liabilities                             4,400,000 4,600,000 5,000,000 5,200,000 6,400,000              
  accumulated other comprehensive loss                             -40,400,000 -42,300,000 -41,000,000 -42,000,000 -42,500,000 -43,200,000 -43,800,000 -44,800,000 -44,300,000 -45,300,000 -42,200,000 -43,100,000 -43,900,000 -44,400,000 -28,000,000 -28,400,000 -29,100,000 -47,200,000 
  common stock - no par value; authorized, 150 million shares; outstanding, 49.3 million and 49.0 million shares at december 31, 2017 and december 31, 2016, respectively                              1,161,700,000                 
  (distributions in excess of accumulated earnings) retained earnings                              -473,000,000                 
  common stock - no par value; authorized, 150 million shares; outstanding, 49.2 million and 49.0 million shares at september 30, 2017 and december 31, 2016, respectively                               1,160,500,000                
  retained earnings                               99,400,000 96,500,000 95,400,000 95,200,000 98,700,000 103,400,000 106,800,000 117,200,000 134,100,000 131,100,000 123,700,000 101,000,000 99,300,000 91,100,000 83,900,000 21,800,000 
  common stock - no par value; authorized, 150 million shares; outstanding, 49.2 million and 49.0 million shares at june 30, 2017 and december 31, 2016, respectively                                1,158,900,000               
  common stock - no par value; authorized, 150 million shares; outstanding, 49.1 million and 49.0 million shares at march 31, 2017 and december 31, 2016, respectively                                 1,157,700,000              
  current assets                                               
  accounts receivable, less allowances                                  32,100,000    38,600,000    33,100,000    8,200,000 
  property - net                                  1,231,600,000    1,269,400,000    1,301,700,000     
  intangible assets - net                                  53,800,000 55,800,000 58,100,000 60,400,000 54,400,000 56,500,000 58,800,000 61,700,000 63,900,000 64,300,000 67,500,000 70,700,000  
  current liabilities                                               
  hc&s cessation related liabilities                                  19,100,000             
  long-term liabilities                                               
  equity                                               
  common stock - no par value; authorized, 150 million shares; outstanding, 49.0 million and 48.9 million shares at december 31, 2016 and 2015, respectively                                  1,157,300,000             
  accounts and other notes receivable                                   38,400,000 29,800,000 38,000,000  36,600,000 43,800,000 35,400,000  29,400,000 41,200,000 32,900,000  
  hc&s cessation related liabilities - current                                   16,900,000 17,600,000 14,600,000          
  accrued pension and postretirement benefits                                   58,600,000 58,700,000 59,500,000  53,200,000 53,700,000 54,700,000  31,000,000 32,900,000 36,500,000 58,900,000 
  common stock - no par value; authorized, 150 million shares; outstanding, 48.9 million and 48.8 million shares at december 31, 2015 and 2014, respectively                                      1,151,700,000         
  common stock - no par value; authorized, 150 million shares; outstanding, 48.8 million and 48.6 million shares at december 31, 2014 and 2013, respectively                                          1,147,300,000     
  non-controlling interest                                          10,900,000     
  income taxes - current                                            5,800,000 12,800,000  
  liabilities and shareholders’ equity                                               
  income taxes payable                                               
  shareholders’ equity                                               
  common stock – no par value; authorized, 150 million shares; outstanding, 42.9 million shares at december 31, 2012                                              939,800,000 
  preferred stock, no par value; authorized, 15 million shares; none issued or outstanding                                               
  net investment                                               
  total shareholders’ equity                                              914,400,000 
  total                                              1,437,300,000 

We provide you with 20 years of balance sheets for Alexander & Baldwin stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Alexander & Baldwin. Explore the full financial landscape of Alexander & Baldwin stock with our expertly curated balance sheets.

The information provided in this report about Alexander & Baldwin stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.